IONS
Ionis Pharmaceuticals, Inc. · Healthcare
EVP Research Eric Swayze sold $655K of Ionis Pharmaceuticals, Inc.
Sold$654,709
$51.63Price
12,680Shares
−27%Stake
What IONS did after the filing
- The stock from Fri, Feb 2 close, $49.75
- −15.5%
- S&P 500, same days
- +4.1%
Measured over 30 trading days, to the Mar 18 close.
Traded Wed, Jan 31. Filed Fri, Feb 2, 2:55 PM ET, during the session. Returns use the Feb 2 close and the Mar 18 close. Not investment advice.